Mouse Models and the Genetics of Diabetes
Is There Evidence for Genetic Overlap Between Type 1 and Type 2 Diabetes?
- 1The Jackson Laboratory, Bar Harbor, Maine
- 2Korea Research Institute of Bioscience and Biotechnology, Daejeon, Korea
- Address correspondence and reprint requests to Dr. Edward H. Leiter, The Jackson Laboratory, 600 Main St., Bar Harbor, ME 04609. E-mail: ehl{at}jax.org
Abstract
In humans, both type 1 and type 2 diabetes exemplify genetically heterogeneous complex diseases in which epigenetic factors contribute to underlying genetic susceptibility. Extended human pedigrees often show inheritance of both diabetes types. A common pathophysiological denominator in both disease forms is pancreatic β-cell exposure to proinflammatory cytokines. Hence, it is intuitive that systemically expressed genes regulating β-cell ability to withstand chronic diabetogenic stress may represent a component of shared susceptibility to both major disease forms. In this review, the authors assemble evidence from genetic experiments using animal models developing clearly distinct diabetes syndromes to inquire whether some degree of overlap in genes contributing susceptibility can be demonstrated. The conclusion is that although overlap exists in the pathophysiological insults leading to β-cell destruction in the currently studied rodent models, the genetic bases seem quite distinct.
- IL, interleukin
- LADA, latent autoimmune diabetes in adults
- MHC, major histocompatibility complex
- ROS, reactive oxygen species
- TNF, tumor necrosis factor
Footnotes
-
This article is based on a presentation at a symposium. The symposium and the publication of this article were made possible by an unrestricted educational grant from Servier.
-
- Accepted April 8, 2005.
- Received March 30, 2005.
- DIABETES











